Universität Zürich, Klinik für Radio-Onkologie, Universitätsspital Zürich, Zurich, Switzerland.
Klinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Köln, Cologne, Germany.
Strahlenther Onkol. 2020 May;196(5):417-420. doi: 10.1007/s00066-020-01603-1.
Stereotactic radiotherapy with its forms of intracranial stereotactic radiosurgery (SRS), intracranial fractionated stereotactic radiotherapy (FSRT) and stereotactic body radiotherapy (SBRT) is today a guideline-recommended treatment for malignant or benign tumors as well as neurological or vascular functional disorders. The working groups for radiosurgery and stereotactic radiotherapy of the German Society for Radiation Oncology (DEGRO) and for physics and technology in stereotactic radiotherapy of the German Society for Medical Physics (DGMP) have established a consensus statement about the definition and minimal quality requirements for stereotactic radiotherapy to achieve best clinical outcome and treatment quality in the implementation into routine clinical practice.
立体定向放射治疗及其形式的颅内立体定向放射外科(SRS)、颅内分次立体定向放射治疗(FSRT)和立体定向体部放射治疗(SBRT),如今已成为治疗恶性或良性肿瘤以及神经或血管功能障碍的一种推荐治疗方法。德国放射肿瘤学会(DEGRO)的放射外科和立体定向放射治疗工作组以及德国医学物理学会(DGMP)的立体定向放射治疗物理与技术工作组,已经就立体定向放射治疗的定义和最低质量要求达成了共识声明,以在常规临床实践中实现最佳临床结果和治疗质量。